• Surplus asset disposition through outright purchase, consignment, or auction
• Turnkey move management including instrument decontamination, decommissioning, packing and shipping, and waste management
• Deinstallation, benchmark testing, and reinstallation of instruments
• Asset management software for tracking inventory, service contracts and maintenance history

Led by Anggie Becorest, senior vice president of business development, the team includes professionals with years of experience in the life sciences, both as bench scientists and in business roles. Team members are strategically located throughout the country, including the key biotech hubs of San Francisco, Boston, and San Diego.

“ALT has always been an end-to-end solutions provider, but now we’ve simplified the process for our clients,” said Becorest. “Many clients don’t have the time or the resources to initiate the complicated stages of reverse supply chain management, such as decommissioning of instruments and chemical removal, and efficiently completing the process through final disposition of the assets. Our solution delivers a single point of contact and eliminates the need for contracting with multiple vendors, individual negotiations, or upfront fees.”